Real-world impact of matched targeted therapy on survival in advanced biliary tract cancer: An international collaborative study.Binbin Zheng-Lin, Tanios Bekaii‐Saab, Celine Hoyek et al.|Journal of Clinical Oncology|2025Cited by 5
Acquired gene alterations potentially related to resistance to anti-HER2 therapy in HER2-positive metastatic colorectal cancer (mCRC).Celine Hoyek, Tanios Bekaii‐Saab, Mitesh J. Borad et al.|Journal of Clinical Oncology|2025Cited by 4
Genomic alterations as predictive biomarkers for cancer-associated thrombosis (CAT) in biliary tract cancer (BTC).Angelo Pirozzi, Mitesh J. Borad, Celine Hoyek et al.|Journal of Clinical Oncology|2025Cited by 1
Systemic therapy for pretreated advanced biliary tract cancer: past developments and recent advancesNaohiro Okano, Shuichi Hironaka, Angelo Pirozzi et al.|Japanese Journal of Clinical Oncology|2025Cited by 1
Clinical and genomic characteristics of hepatocellular carcinoma-cholangiocarcinoma: Insights from real-world data.Oluseyi Abidoye, Tanios Bekaii‐Saab, Isabela Chang et al.|Journal of Clinical Oncology|2025Cited by 1